| Alpha Stem Cell Clinics Network Expansion | Stanford University | The Stanford Alpha Stem Cell Clinic |
$6,920,810 |
| Quest – Discovery Stage Research Projects | Stanford University | Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells |
$1,968,456 |
| Clinical Trial Stage Projects | Stanford University | Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients |
$10,642,420 |
| Clinical Trial Stage Projects | Stanford University | Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. |
$10,563,822 |
| Late Stage Preclinical Projects | Stanford University | Autologous Gene Corrected Sinus Basal Cells to Treat Serious Cystic Fibrosis Sinus Disease |
$6,000,000 |
| Late Stage Preclinical Projects | Stanford University | Genome Editing of Autologous Hematopoietic Stem Cells to Treat Sickle Cell Disease |
$4,849,363 |
| Preclinical Development Awards | Stanford University | Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1 |
$874,877 |
